Benefits
Endurance: a 20% gain reported in one 12-person single-dose study of purified Rg1
In a randomized crossover study, 12 young men took a single 5 mg dose of purified ginsenoside Rg1, the main active from Panax notoginseng, one hour before high-intensity cycling, and a separate 12-person arm lasted about 20% longer before exhaustion than on placebo. A 2005 trial reported better endurance with 1,350 mg of plain Panax notoginseng, a much larger dose of the whole herb than a Senactiv serving provides. No cited study tested the finished blend taken daily, and the authors of the recent Rg1 studies disclose a patent related to Senactiv.
Glycogen refueling: the 370% figure is not reported in the studies cited here
The widely repeated claim of 370% faster glycogen refueling is not reported in any of the four studies cited on this page. The closest one (Hou 2015, PLoS One) tested purified ginsenoside Rg1 and reported a better balance of inflammatory signals in exercising muscle, not a measured recovery or training benefit. Treat the 370% figure as a marketing number until it is published in a trial of the blend itself.
Citrate synthase and ATP production
Citrate synthase is an enzyme muscle uses to produce energy with oxygen, and a 47% increase is often quoted for this ingredient. None of the studies cited here reports that number, and no cited study shows that a change in this enzyme produced better training results or more everyday energy. Treat it as a lab measurement claim rather than a proven benefit.
Senescent cell clearance
In a 12-person crossover study, 9 of 12 men who took a single 5 mg dose of purified ginsenoside Rg1 (not the Senactiv blend) had no detectable signal from an aging-cell marker in muscle after exercise, while the placebo condition did not change. That is a marker in a muscle sample from 12 people after one dose. Whether it leads to stronger, healthier muscle or a longer healthspan has not been tested.
Mechanism of action
Ginsenoside Rg1 anti-inflammatory and mitochondrial signaling
In a small human study, purified ginsenoside Rg1 taken before exercise shifted the balance of inflammatory signals in working muscle. The further steps often described, such as building more mitochondria and raising energy-producing enzyme activity, are proposed explanations rather than things the cited human studies measured and confirmed.
Insulin receptor and GLUT4 preservation during exercise
Muscle refills its fuel stores using a glucose transporter called GLUT4, and hard exercise can disturb that system. The idea that Senactiv protects GLUT4 and insulin signalling is a proposed mechanism, not a measured one: none of the four studies cited on this page reports GLUT4 or insulin receptor outcomes in people.
Senolytic clearance of β-galactosidase-positive cells
After a single 5 mg dose of purified Rg1, researchers saw less of an aging-cell marker in exercised muscle, and a 2021 report from the same group found lower stem cell aging markers. The step from those markers to actually building fresh, better performing muscle has not been shown in people.
Clinical trials
Randomized, placebo-controlled human study of purified ginsenoside Rg1, the isolated active from Panax notoginseng, taken around exercise. Published outcome: the balance of inflammatory signals in exercising skeletal muscle (Hou et al. 2015, PLoS One). This study tested the isolated compound, not the finished Senactiv blend.
Healthy young men exercising in a laboratory.
What this study reported was an improved balance of inflammatory signals in exercising muscle after purified Rg1 supplementation. The 20% endurance figure comes from a different 12-person study, and the 47% citrate synthase figure is not reported in any study cited on this page. The Rg1 was supplied by the manufacturer, NuLiv Science, and independent replication is needed.
Randomized, double-blind, placebo-controlled crossover study in 12 young men, testing a single 5 mg dose of purified ginsenoside Rg1 (not the finished Senactiv blend) one hour before high-intensity cycling, with muscle biopsies. Published in the peer-reviewed Journal of Ginseng Research in 2019.
12 healthy young men (mean age 21). Randomized, double-blind, placebo-controlled crossover; 5 mg purified Rg1 (active in Senactiv®) or placebo 1 hour before high-intensity cycling at 70% VO₂max. Vastus lateralis biopsies pre- and post-exercise. Separate 12-pt arm tested cycling time-to-exhaustion.
9 of 12 Rg1 participants showed complete elimination of senescence-associated β-galactosidase (SA-β-gal) signals in exercised muscle vs no change in placebo (p<0.05). Cycling time-to-exhaustion at 80% VO₂max increased ~20% with Rg1. The authors describe this as the first human sign of aging-cell clearance in exercising muscle. The limits are large: 12 participants, one dose of an isolated compound rather than the blend, marker-based outcomes, and authors from this research group who disclose a patent related to Senactiv.